The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
To enable company to be future-ready by tapping potential in CDMO space
Modi stressed the need to ensure that the entire Covid infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes, and human resources
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
R&D center would be doing a lot of new product generation projects, process optimization, scale-up and product life cycle management work, full synthetic labs, the kilo labs, the process safety labs, and the population lab
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
